Background
Rationale
Objectives
Methods
1. Physiological changes |
• Hemostasis and wound healing |
2. Pathological changes |
• Endogenously induced primary pathologies |
- Disseminated Intravascular Coagulation (DIC) |
• Activation of coagulation |
• Insufficient anticoagulant mechanisms |
• Increased fibrin (ogen) olysis (early phase) |
• Suppression of fibrinolysis (late phase) |
- Acute coagulopathy trauma-shock (ACOTS) |
• Activated protein C-mediated suppression of coagulation |
• Activated protein C-mediated increased fibrinolysis |
• Exogenously induced secondary pathologies that modify DIC and ACOTS |
- Anemia-induced coagulopathy |
- Hypothermia-induced coagulopathy |
- Acidosis-induced coagulopathy |
- Dilutional coagulopathy |
- Others |
Eligibility criteria
Study design
Participants
Interventions
Comparators
Timing
Language
Information sources and search strategies
Data records
Data items
Outcomes and prioritization
Risk of bias individual studies
Data synthesis
Meta-bias
Confidence of cumulative estimate
Results
The included studies
Reference (year) | Design | Patients (n) | Inclusion criteria | Injury Severity Score (ISS) | Sampling time (n) | Trauma-induced coagulopathy |
---|---|---|---|---|---|---|
Mean (SD) or median (25–75% quartile) | ||||||
[35] (2011) | 80 | Full trauma activation | ACOTS 34(30–43) Non-ACOTS 17(10–25) | Median 68 min post injury (1) | ACOTS | |
[36] (2012) | Prospective cohort (s) | 203 | Highest-level trauma team activation | 25.2 (13.8) | On arrival at ED 6,12,24 h after admission (4) | Acute traumatic coagulopathy |
[37] (2012) | Prospective | 132 | Highest-level trauma activation system | High histone 30.5(13.0) Low histone 22.8(13.1) | Within 10 min of ED arrival 6 h after admission (2) | Traumatic injury |
[38] (2013) | Prospective cohort (m) | 80 | Full trauma team activation | iTBI 35(32–37) sTBI + extracranial injury (sTBI/E) 25(15–26) Non-TBI 10(7–22) | Within 2 h after injury (1) | ACOTS |
[39] (2013) | A subset of PROMMT | 1198 | Highest-level trauma activation | PTINR Coagulopathic 31.1(15.5) Non-coagulopathic 23.9(14.4) APTT Coagulopathic 35.6(16.6) Non-coagulopathic 24.6(14.0) | Not shown | Acute traumatic coagulopathy |
[40] (2016) | Prospective (1) | 57 | Severe trauma ISS > 9, at least 1 AIS > 3 | ACOTS Non-ACOTS, not shown | Within 12 h after arrival to ED (1) | ACOTS |
[41] (2017) | Prospective cohort (s) | 300 | Full trauma activation | ATC 23(10–34) Non-ATC 9(4–22) | Within 20 min of arrival in the ED (1) | Acute traumatic coagulopathy |
[42] (2013) | Prospective (s) | 57 | Severe trauma ISS > 9, at least 1 AIS > 3 | ACOTS Non-ACOTS, not shown | Within 12 h after arrival to ED (1) | ACOTS |
Reference (year) | Diagnosis | Control | Normal control | Activated protein C Methods | Thrombin Surrogate markers | PAI-1 |
---|---|---|---|---|---|---|
[35] (2011) | APTT and/or PTINR above normal reference | Non-ACOTS | No | Yes ELISA | Yes PF1 + 2, TAT | Yes |
[36] (2012) | PTINR> 1.3 | No | No | Yes Enzyme capture assay (banzamidine) | No | No |
[37] (2012) | No | Low histone | No | Yes Enzyme capture assay (banzamidine) | No | No |
[38] (2013) | APTT and/or PTINR above normal reference | NA | No | Yes ELISA | Yes PF1 + 2, TAT | Yes |
[39] (2013) | PT INR 1.3, APTT> 35 s. | Non-coagulopathic | No | Yes Not shown | No | No |
[40] (2016) | PT ratio > 1.2 | Normal control Non-ACOTS | Healthy volunteer | Yes ELISA | No | No |
[41] (2017) | Amplitude of clot at 5 min by ROTEM | Non-ATC | No | Yes Enzyme capture assay (benzamidine) | Yes PF1 + 2 | Yes |
[42] (2013) | PT ratio > 1.2 | Normal control Non-ACOTS | Healthy volunteer | Yes Prothrombinase activity | Yes Soluble fibrin | No |
Reference (year) | Main results |
---|---|
[35] (2011) | ACOTS showed lower levels of protein C, and higher levels of sTM and D-dimer however, there were no differences in the levels of activated protein C, PF1 + 2, TAT, t-PA, or PAI-1 between ACOTS and non-ACOTS. In ACOTS, activated protein C showed no correlation with PF1 + 2. ACOTS showed consumption coagulopathy. |
[36] (2012) | Patients with ISS > 15 and BD > − 6 showed high activated protein C and lower protein C levels. Activated protein C > 6 ng/mL was associated with prolonged PT, APTT, low FV and FVIII activities, and high levels of t-PA and D-dimer. Markers of thrombin generation, sTM and PAI-1 were not measured. Neither activated protein C nor protein C levels were shown in patients with acute traumatic coagulopathy (defined as PTINR> 1.3). |
[37] (2012) | The high histone group showed higher ISS, and activated protein C, t-PA, and D-dimer levels. The markers of thrombin generation, sTM and PAI-1 were not measured. There were no differences between high and low histone groups with regard to the levels of protein C, AT, or BD, or the FVII, FV and FVIII activities. |
[38] (2013) | The sTBI/E group showed high ISS and a high incidence of ACOTS. The sTBI/E groups showed decreased protein C and AT levels, and increased D-dimer and sTM levels. There were no differences in the levels of BD, activated protein C, PF1 + 2, TAT, t-PA, or PAI-1 among the three groups. |
[39] (2013) | PTINR-based coagulopathy: The coagulopathy group showed higher activated protein C levels and lower protein C levels but there were no differences in the D-dimer levels. Both protein C and activated protein C were independent predictors of coagulopathy. APTT-based coagulopathy: Coagulopathy was associated with increased activated protein C and D-dimer levels and decreased protein C levels. There were inconsistencies between PTINR- and APTT-based coagulopathy. Factors V, VII, and VIII were decreased in both types of coagulopathy. |
[40] (2016) | Activated protein C levels were more decreased in ACOTS than controls and non-ACOTS. ACOTS showed the same results as DIC. |
[41] (2017) | ATC showed higher activated protein C, PF1 + 2, PAP and D-dimer levels and lower protein C, AT and fibrinogen levels in comparison to non-ATC. Activated protein C reduced the Factors V and VIII activities and the fibrinogen levels in a dose-dependent manner, while the thrombin generation capacity was preserved. The PAI-1 levels did not differ between patients with low and high activated protein C levels. |
[42] (2013) | ACOTS showed normal prothrombinase activity, increased soluble fibrin and sTM, and decreased AT in comparison to normal controls and non-ACOTS. The results related to ACOTS coincided with those of DIC. |
Reference (year) | Design | Patients (n) | Inclusion criteria | Injury Severity Score (ISS) | Sampling time (n) | Trauma-induced coagulopathy |
---|---|---|---|---|---|---|
Median (25–75% quartile) | ||||||
[8] (2007) | Prospective cohort (s) | 208 | Full trauma team activation | 17(9–26) | Arrival in the trauma room (1) | Acute traumatic coagulopathy |
[9] (2007) | Prospective cohort (s) | 39 | Traumatic brain injury | 24(14–30) | Arrival in the trauma room (1) | Coagulopathy |
[10] (2008) | Prospective cohort (s) | 208 | Major trauma | 17(9–26) | Immediately on admission to ED (1) | Acute coagulopathy of trauma |
[43] (2009) | Prospective (s) | 42 | Initial blood sample collected within 1 h | ACT Non-ACT, not shown | Within 1 h of hospital presentation (1) | Acute coagulopathy of trauma |
[44] (2010) | Prospective (s) | 58 | Not shown | With coagulopathy Without coagulopathy, not shown | Within 1 h of arrival at hospital | Coagulopathy |
[45] (2011) | Prospective cohort (s) | 334 | Severe polytrauma ISS > 15 | ISS 15–20, 30–50, > 50 | Immediately after ED admission (1) | Trauma-induced coagulopathy |
[46] (2013) | Prospective cohort (s) | 303 | Trauma team activation | Fibrinolytic activity by PAP and ML Normal 6(1–10) Moderate 17(9–28) Severe 25(17–38) | Within 20 min of arrival in the ED (1) | None |
[47] (2014) | Prospective cohort (s) | 163 | Highest-level trauma team activation | Fibrinolytic activity by PAP Normal 9(2–16) Moderate 21(13–25) Severe 28(17–35) | On admission and prior to administration blood product (1) | None |
[48] (2016) | Prospective cohort (s) | 72 | Highest-level trauma team activation | Hyperfibrinolytic by rapid TEG 33(22–41) | The earliest possible time point after injury (1) | Trauma-induced coagulopathy |
Reference (year) | Diagnosis | Control | Normal control | Thrombin (surrogate) | PAI-1 |
---|---|---|---|---|---|
[8] (2007) | No | No | No | Yes | Yes |
[9] (2007) | No | No | No | Yes | Yes |
[10] (2008) | No | No | No | Yes | Yes |
[43] (2009) | PT > 18 s (PTINR> 1.5) | Non-ACT | Healthy volunteer | Yes | No |
[44] (2010) | ISTH DIC | Without coagulopathy | Healthy volunteer | Yes | No |
[45] (2011) | NA | ISS 15–29 | No | Yes | No |
[46] (2013) | NA | Normal fibrinolytic activity | No | Yes | Yes |
[47] (2014) | NA | Normal fibrinolysis | No | No | Yes |
[48] (2016) | No | Healthy volunteer | Healthy volunteer | No | Yes |
Reference (year) | Main results |
---|---|
[8] (2007) | PF1 + 2 increased as the ISS increased. In the presence of increased BD, protein C fell with increasing levels of PF1 + 2 and sTM. Low protein C was associated with low PAI-1 and increased t-PA and D-dimer levels. These changes were associated with prolonged PT and APTT. |
[9] (2007) | Increasing ISS and BD were associated with high PF1 + 2, sTM levels and low levels of protein C levels. Brain injury and increased BD resulted in high t-PA and D-dimer levels. None of the results included the PAI-1 levels. These changes were associated with prolonged PT and APTT. |
[10] (2008) | PF1 + 2 increased with increased ISS. Protein C fell with increasing levels of sTM. t-PA was increased in patients with BD > − 7.7; this was unrelated to PF1 + 2. The t-PA and D-dimer levels decreased in parallel with increases in PAI-1. |
[43] (2009) | ACT patients had lag times that was 68% shorter and peak thrombin generation was three-fold higher in comparison to normal patients, indicating the presence of circulating procoagulants that were capable of initiating systemic coagulation. Increased systemic thrombin generation was associated with slower inhibition of thrombin generation and decreased antithrombin levels. |
[44] (2010) | Patients with coagulopathy had higher procoagulant activity, tissue factor-like activity and D-dimer in comparison to normal controls and patients without coagulopathy. In patients with coagulopathy, 79% of the procoagulant activity was due to tissue factor-like activity, which was higher than that in patients without coagulopathy. |
[45] (2011) | Patients with higher ISS (30–50 and > 50) showed extremely elevated PF1 + 2, TAT, and lower AT levels, which were associated with increased BD. Patients with higher ISS also showed lower platelet counts and fibrinogen levels, and prolonged PT and APTT. |
[46] (2013) | In patients with severe fibrinolytic activity, the PAP, t-PA and D-dimer levels were higher than in patients with normal and moderate fibrinolysis. However, the PAI-1 levels did not change in association with changes in t-PA, D-dimer, and PAP levels. Patients with severe fibrinolytic activity also showed high PF1 + 2 and low AT levels. The PAP and D-dimer levels were increased in line with increases in the BD. |
[47] (2014) | Severe fibrinolysis was associated with high active and total t-PA and a reduction of active and total PAI-1. Increased active t-PA and reduced active PAI-1 were both associated with fibrinolysis, as measured by PAP. |
[48] (2016) | The total PAI-1 levels in hyperfibrinolytic trauma and healthy controls were equal; however, the levels of active PAI-1 were higher than in controls. The ratio of active to complexed PAI-1/t-PA was lower in hyperfibrinolytic trauma than in controls. Conversely, both total t-PA and active t-PA were higher than in healthy controls. Massive t-PA release overwhelms free PAI-1. There is no PAI-1 degradation. |
Study quality
Activated protein C (Tables 2, 3 and 4)
Thrombin generation and PAI-1 (Tables 5, 6 and 7)
The definition and diagnostic criteria of ACOTS
Discussion
Conclusions
Key messages
-
None of the studies searched in our systematic review showed direct cause and effect relationships between activated protein C and the suppression of coagulation and increased fibrinolysis in ACOTS.
-
The lack of a clear definition and diagnostic criteria, and various terminologies that are used to refer to ACOTS may be one of the reasons for these results.